List of Tables
Table 1. Global Gastroparesis Drugs Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Gastroparesis Drugs Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Gastroparesis Drugs Market Competitive Situation by Manufacturers in 2025
Table 4. Global Gastroparesis Drugs Sales (Kg) of Key Manufacturers (2021–2026)
Table 5. Global Gastroparesis Drugs Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Gastroparesis Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Gastroparesis Drugs Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Gastroparesis Drugs Average Price (US$/mg) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Gastroparesis Drugs, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Gastroparesis Drugs, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Gastroparesis Drugs, Product Types and Applications
Table 12. Global Key Manufacturers of Gastroparesis Drugs, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gastroparesis Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Gastroparesis Drugs Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Gastroparesis Drugs Sales by Region (Kg), 2021–2026
Table 18. Global Gastroparesis Drugs Sales Market Share by Region (2021–2026)
Table 19. Global Gastroparesis Drugs Sales by Region (Kg), 2027–2032
Table 20. Global Gastroparesis Drugs Sales Market Share by Region (2027–2032)
Table 21. Global Gastroparesis Drugs Revenue by Region (US$ Million), 2021–2026
Table 22. Global Gastroparesis Drugs Revenue Market Share by Region (2021–2026)
Table 23. Global Gastroparesis Drugs Revenue by Region (US$ Million), 2027–2032
Table 24. Global Gastroparesis Drugs Revenue Market Share by Region (2027–2032)
Table 25. North America Gastroparesis Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Gastroparesis Drugs Sales by Country (Kg), 2021–2026
Table 27. North America Gastroparesis Drugs Sales by Country (Kg), 2027–2032
Table 28. North America Gastroparesis Drugs Revenue by Country (US$ Million), 2021–2026
Table 29. North America Gastroparesis Drugs Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Gastroparesis Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Gastroparesis Drugs Sales by Country (Kg), 2021–2026
Table 32. Europe Gastroparesis Drugs Sales by Country (Kg), 2027–2032
Table 33. Europe Gastroparesis Drugs Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Gastroparesis Drugs Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Gastroparesis Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Gastroparesis Drugs Sales by Region (Kg), 2021–2026
Table 37. Asia Pacific Gastroparesis Drugs Sales by Region (Kg), 2027–2032
Table 38. Asia Pacific Gastroparesis Drugs Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Gastroparesis Drugs Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Gastroparesis Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Gastroparesis Drugs Sales by Country (Kg), 2021–2026
Table 42. Latin America Gastroparesis Drugs Sales by Country (Kg), 2027–2032
Table 43. Latin America Gastroparesis Drugs Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Gastroparesis Drugs Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Gastroparesis Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Gastroparesis Drugs Sales by Country (Kg), 2021–2026
Table 47. Middle East and Africa Gastroparesis Drugs Sales by Country (Kg), 2027–2032
Table 48. Middle East and Africa Gastroparesis Drugs Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Gastroparesis Drugs Revenue by Country (US$ Million), 2027–2032
Table 50. Global Gastroparesis Drugs Sales (Kg) by Type (2021–2026)
Table 51. Global Gastroparesis Drugs Sales (Kg) by Type (2027–2032)
Table 52. Global Gastroparesis Drugs Sales Market Share by Type (2021–2026)
Table 53. Global Gastroparesis Drugs Sales Market Share by Type (2027–2032)
Table 54. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Gastroparesis Drugs Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Gastroparesis Drugs Revenue Market Share by Type (2021–2026)
Table 57. Global Gastroparesis Drugs Revenue Market Share by Type (2027–2032)
Table 58. Global Gastroparesis Drugs Price (US$/mg) by Type (2021–2026)
Table 59. Global Gastroparesis Drugs Price (US$/mg) by Type (2027–2032)
Table 60. Global Gastroparesis Drugs Sales (Kg) by Application (2021–2026)
Table 61. Global Gastroparesis Drugs Sales (Kg) by Application (2027–2032)
Table 62. Global Gastroparesis Drugs Sales Market Share by Application (2021–2026)
Table 63. Global Gastroparesis Drugs Sales Market Share by Application (2027–2032)
Table 64. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Gastroparesis Drugs Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Gastroparesis Drugs Revenue Market Share by Application (2021–2026)
Table 67. Global Gastroparesis Drugs Revenue Market Share by Application (2027–2032)
Table 68. Global Gastroparesis Drugs Price (US$/mg) by Application (2021–2026)
Table 69. Global Gastroparesis Drugs Price (US$/mg) by Application (2027–2032)
Table 70. Sumitomo Company Information
Table 71. Sumitomo Description and Business Overview
Table 72. Sumitomo Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 73. Sumitomo Gastroparesis Drugs Product
Table 74. Sumitomo Recent Developments/Updates
Table 75. Cadila Pharmaceuticals Company Information
Table 76. Cadila Pharmaceuticals Description and Business Overview
Table 77. Cadila Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 78. Cadila Pharmaceuticals Gastroparesis Drugs Product
Table 79. Cadila Pharmaceuticals Recent Developments/Updates
Table 80. Sanofi Company Information
Table 81. Sanofi Description and Business Overview
Table 82. Sanofi Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 83. Sanofi Gastroparesis Drugs Product
Table 84. Sanofi Recent Developments/Updates
Table 85. Teva Company Information
Table 86. Teva Description and Business Overview
Table 87. Teva Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 88. Teva Gastroparesis Drugs Product
Table 89. Teva Recent Developments/Updates
Table 90. Johnson & Johnson Company Information
Table 91. Johnson & Johnson Description and Business Overview
Table 92. Johnson & Johnson Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 93. Johnson & Johnson Gastroparesis Drugs Product
Table 94. Johnson & Johnson Recent Developments/Updates
Table 95. Pfizer Company Information
Table 96. Pfizer Description and Business Overview
Table 97. Pfizer Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 98. Pfizer Gastroparesis Drugs Product
Table 99. Pfizer Recent Developments/Updates
Table 100. Kyowa Kirin Pharmaceuticals Company Information
Table 101. Kyowa Kirin Pharmaceuticals Description and Business Overview
Table 102. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 103. Kyowa Kirin Pharmaceuticals Gastroparesis Drugs Product
Table 104. Kyowa Kirin Pharmaceuticals Recent Developments/Updates
Table 105. Hanmi Pharm Company Information
Table 106. Hanmi Pharm Description and Business Overview
Table 107. Hanmi Pharm Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 108. Hanmi Pharm Gastroparesis Drugs Product
Table 109. Hanmi Pharm Recent Developments/Updates
Table 110. Ani Pharmaceuticals Company Information
Table 111. Ani Pharmaceuticals Description and Business Overview
Table 112. Ani Pharmaceuticals Gastroparesis Drugs Sales (Kg), Revenue (US$ Million), Price (US$/mg), and Gross Margin (2021–2026)
Table 113. Ani Pharmaceuticals Gastroparesis Drugs Product
Table 114. Ani Pharmaceuticals Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Gastroparesis Drugs Distributors List
Table 118. Gastroparesis Drugs Customers List
Table 119. Gastroparesis Drugs Market Trends
Table 120. Gastroparesis Drugs Market Drivers
Table 121. Gastroparesis Drugs Market Challenges
Table 122. Gastroparesis Drugs Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Gastroparesis Drugs
Figure 2. Global Gastroparesis Drugs Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Gastroparesis Drugs Market Share by Type: 2025 & 2032
Figure 4. Prokinetic Agents Product Picture
Figure 5. Antiemetic Agents Product Picture
Figure 6. Others Product Picture
Figure 7. Global Gastroparesis Drugs Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Gastroparesis Drugs Market Share by Application: 2025 & 2032
Figure 9. Diabetic Gastroparesis
Figure 10. Idiopathic Gastroparesis
Figure 11. Global Gastroparesis Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Gastroparesis Drugs Market Size (US$ Million), 2021–2032
Figure 13. Global Gastroparesis Drugs Sales (Kg), 2021–2032
Figure 14. Global Gastroparesis Drugs Average Price (US$/mg), 2021–2032
Figure 15. Gastroparesis Drugs Report Years Considered
Figure 16. Gastroparesis Drugs Sales Share by Manufacturers in 2025
Figure 17. Global Gastroparesis Drugs Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Gastroparesis Drugs Players: Market Share by Revenue in Gastroparesis Drugs in 2025
Figure 19. Gastroparesis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Gastroparesis Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Gastroparesis Drugs Sales Market Share by Country (2021–2032)
Figure 22. North America Gastroparesis Drugs Revenue Market Share by Country (2021–2032)
Figure 23. U.S. Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Gastroparesis Drugs Sales Market Share by Country (2021–2032)
Figure 26. Europe Gastroparesis Drugs Revenue Market Share by Country (2021–2032)
Figure 27. Germany Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Gastroparesis Drugs Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Gastroparesis Drugs Revenue Market Share by Region (2021–2032)
Figure 34. China Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Gastroparesis Drugs Sales Market Share by Country (2021–2032)
Figure 44. Latin America Gastroparesis Drugs Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Gastroparesis Drugs Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Gastroparesis Drugs Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Gastroparesis Drugs Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Gastroparesis Drugs by Type (2021–2032)
Figure 54. Global Revenue Market Share of Gastroparesis Drugs by Type (2021–2032)
Figure 55. Global Gastroparesis Drugs Price (US$/mg) by Type (2021–2032)
Figure 56. Global Sales Market Share of Gastroparesis Drugs by Application (2021–2032)
Figure 57. Global Revenue Market Share of Gastroparesis Drugs by Application (2021–2032)
Figure 58. Global Gastroparesis Drugs Price (US$/mg) by Application (2021–2032)
Figure 59. Gastroparesis Drugs Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
